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Abstract
The 24-item Brief Psychiatric Rating Scale (BPRS, version4.0) enables the rater to measure
psychopathology severity. Still, little is known about the BPRS's reliability and validity outside of
the psychosis spectrum. The aim of this study was to examine the factorial structure and
sensitivity to change of the BPRS in patients with unipolar depression. Two hundred and forty
outpatients with unipolar depression were administered the 24-item BPRS. Assessments were
conducted at intake and at post-treatment in a Crisis Intervention Centre. An exploratory factor
analysis of the 24-item BPRS produced a six-factor solution labelled “Mood disturbance”,
“Reality distortion”, “Activation”, “Apathy”, “Disorganization”, and “Somatization”. The
reduction of the total BPRS score and dimensional scores, except for “Activation”, indicates that
the 24-item BPRS is sensitive to change as shown in patients that appeared to have benefited from
crisis treatment. The findings suggest that the 24-item BPRS could be a useful instrument to
measure symptom severity and change in symptom status in outpatients presenting with unipolar
depression.
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1. Introduction
In busy psychiatric services, short, simple-to-administer, and informative measures are
needed to assess psychopathological symptoms. The Brief Psychiatric Rating Scale (BPRS)
is one of the most widely-used instruments enabling the clinician to quickly gather
information about the possible presence and severity of various psychiatric symptoms. The
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BPRS exists in various forms, varying in the number and type of symptoms assessed, clarity
of anchor point definitions, and administration and rating instructions. The original 16-item
BPRS, developed in the early sixties (Overall and Gorham, 1962), was extended to 18 items
(Overall et al., 1967). This latter version was used for many years. Then, in order to increase
its sensitivity to psychotic and affective disorders as well as to be used with patients living
in the community, the BPRS was expanded to 24 items (the 24-item BPRS, version 2;
Lukoff et al., 1986a, 1986b). Compared to previous versions of the BPRS, the manual of
administration of the 24-item BPRS (version 4.0; Ventura et al., 1993b) offers a more
detailed semi-structured interview containing more probe questions for each symptom. The
24-item BPRS also provides supplementary rules for rating (e.g., delusions) and the anchor
points are better defined. Additional guidelines for interviews and operational definitions
regarding the frequency of symptoms and social functioning alterations are available
(Morosini et al., 1995; Morosini and Casacchia, 1995).
With specific regard to the 24-item BPRS, some recent analyses of the underlying construct
of the symptom items produced a four-factor solution: Negative Symptoms, Positive
Symptoms, Manic-hostility and Anxiety–Depression (Ventura et al., 2000). This structure
remains stable across the longitudinal course of schizophrenia (Kopelowicz et al., 2008) and
cross-culturally (Ruggeri et al., 2005). The 24-item BPRS is also a sensitive measure of
symptom reduction occurring after rehabilitation intervention (Ballerini et al., 2007;
Gigantesco et al., 2006; Inch et al., 1997; Pioli et al., 2006). Moreover, less clinically
experienced professionals could administer the BPRS 4.0 with high levels of inter-rater
reliability (Roncone et al., 1999; Ventura et al., 1993a). However, the use of the 24-item
BPRS has, until recently, been mostly limited to severely mentally ill hospitalized patients
(e.g., Adams and El-Mallakh, 2009; Anderson et al., 2004; Biancosino et al., 2007;
Kopelowicz et al., 2008; Ventura et al., 2000). Shafer (2005) suggested studying the factor
structure of BPRS in patients with other psychiatric diagnosis than schizophrenia. Little is
known about the 24-item BPRS with regard to mood disorders. As a broad-based
instrument, the 24-item BPRS (version 4.0) may contribute to detecting different symptoms
(e.g., psychotic features) which are not covered by more specific assessment instruments
(e.g., BDI: Beck Depression Inventory, Beck et al., 1988; HDRS: Hamilton Depression
Rating Scale, Hamilton, 1980; MADRS: Montgomery and Asberg Depression Rating,
Montgomery and Asberg, 1979). This is probably due to the fact that clinicians and
researchers prefer to use specific self-administered scales which are in accordance with “a
view of mental disorders as independent entities” (Biancosino et al., 2010, p. 329). This may
lead clinicians to ignore other symptoms (e.g., somatic concerns, motor retardation) which
could also have a deleterious influence on social functioning.
Research has just begun to explore the validity of the 24-item BPRS in assessing symptom
severity in other specific psychiatric disorders such as mania in inpatients (Picardi et al.,
2008). More recently, the factor structure of the 18-item BPRS was examined in a sample of
inpatients with unipolar depression assessed shortly after admission (Biancosino et al.,
2010). The authors extracted four factors (“Apathy”, “Dysphoria”, “Depression” and
“Psychoticism”) but did not report the sensitivity to change of the instrument and the
reliability of the clinical raters. Moreover, the 18-item version of the BPRS suffers from
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several weaknesses (e.g., lack of specific anchors points). Thus, the psychometric
characteristics of the BPRS remain incomplete.
Furthermore to date, no study has examined the question of whether the 24-item BPRS
could also be a useful instrument when administered to outpatients with a mood disorder
admitted to a Crisis Intervention Centre (CIC). CICs are community-based psychiatric units
which serve as an alternative to voluntary hospitalizations offering intensive, time-limited
(6–8 weeks) individual and group therapy, social assistance, as well as, in some cases, the
possibility of spending the night in the centre (Bacchetta et al., 2009). For such a treatment
context, it becomes essential to have brief, accurate psychopathological instruments which
are sensitive to changes during pharmacological treatment (Eiselé et al., 1991) and to
document the efficacy of psychological therapies.
Thus, the aim of this study was to investigate the factor structure of the French version of
the 24-item BPRS and to examine its sensitivity to change in a sample of outpatients with
unipolar depression treated in a CIC.
2. Methods
2.1. Patients
Two hundred and forty outpatients (62.5% women) with unipolar depression were included.
The patients' average age was 40.85 years (S.D. = 10.89; range, 19–70). They were recruited
from consecutive admissions in one of the CICs of the University Hospital of Geneva,
Switzerland. At admission, patients were carefully interviewed by a psychiatrist. During this
unstructured interview were examined psychiatric symptoms, social conditions, trigger
events as well as present and past history including substance and alcohol abuse and
dependence, mood swings or mood disorders induced by medical conditions. Patients'
records were also examined. This was done in order to exclude medical conditions
associated with psychiatric symptoms and to identify possible bipolar disorders (type I or
type II) or other comorbidities (e.g. substance and alcohol dependence). In case of doubt,
patients were referred to a specialized bipolar unit or other specialized units (substance or
alcohol) for diagnosis ascertainment and treatment. According to the ICD-10, 136 (56.66%)
were diagnosed with depressive mood disorder (F32) and 104 (43.34%) with recurrent
depressive disorder (F33). Clinical diagnoses were ascertained by two independent
psychiatrists. In the depressive mood disorder group, 6 (4.41%) presented a mild depressive
episode (F32.0), 61 (44.85%) a moderate depressive episode (F32.1) and 69 (50.73%) a
severe depressive episode without psychotic symptoms (F32.2). In the recurrent depressive
disorder group, 6 (5.76%) had a mild depressive episode (F33.0), 53 (50.96%) a moderate
depressive episode (F33.1), 36 (34.61%) a severe depressive episode without psychotic
symptoms (F33.2), 2 (1.92%) a severe depressive episode with psychotic symptoms (F33.3),
1(0.96%) was then in remission (F33.4) and 6 (5.76%) presented an unspecified episode.
Most of the patients (92.91%) received psychotropic medication and 77.50% took more than
one medication. One hundred and fifty (62.50%) were either employed or students. The
most common symptoms motivating treatment at the CIC were suicidal ideation or suicidal
attempt (43.75%), depressed mood (33.75%) and anxiety (10.83%). The prevalent trigger
events were couple difficulties (42.50%), conflicts at work (22.90%), family situation
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(16.66%), miscellaneous (12.08%) and unclear (4.10%). Patients received a 6–8 weeks crisis
treatment combining pharmacological treatment and intensive individual and group therapy
(for full descriptions see Bacchetta et al. (2009)).
2.2. Measures
The 24-item BPRS (version 4.0) assesses 24 psychiatric symptoms (Ventura et al., 1993b).
The presence and severity of psychiatric symptoms were rated on a Likert scale ranging
from 1 (not present) to 7 (extremely severe). Thus, possible scores vary from 24 to 168 with
lower scores indicating less severe psychopathology. The 24-item BPRS interviews and
ratings were assessed following the 24-item BPRS administration manual, including
Morosini et al.'s (1995) and Morosini and Casacchia's (1995) adjunctions, which we
translated and adapted into French (Zanello et al., 2004, unpublished manuscript).
As an independent measure of clinical change we used the Symptom Checklist – Revised
(SCL-90 R) (Derogatis, 1977). The SCL-90 R is a self-rating scale composed of 90 items
rated from 0 (not at all) to 4 (extremely). The SCL-90 R enables to calculate the Global
Severity Index (GSI).
2.3. BPRS training
Research assistants (five psychologists) received BPRS training before assessing patients.
The training consisted of (a) 3 h of formal teaching introducing BPRS rationale, interview
characteristics', description and scoring of items, (b) a video-training consisting in eight
video-taped BPRS interviews with “gold standard” consensus ratings obtained from four
senior psychologists previously trained by one of us (J.V.) with good intra-class reliability
(ICC > 0.87), and (c) clinical practice in real situations was given to each research assistant
as he participated in four in vivo BPRS interviews (two conducted by A.Z. and two
conducted by the trainee under A.Z.'s supervision). The quality assurance was provided over
time study, and each BPRS interview was discussed with the first author.
2.4. Procedure
The 24-item BPRS was included in the protocol of a study approved by the local ethical
committee. Participants gave written informed consent before being administered a battery
of questionnaires including the 24-item BPRS and the SCL-90 R. Assessments were made
by a research assistant at intake within one week of admission and at discharge after 8 weeks
± 1 week. Ratings considered the last two-week period of psychiatric symptoms.
2.5. Statistical analyses
First, the suitability of the data for factor analysis was verified. The distribution of the BPRS
item scores was inspected with the Kolmogorov–Smirnov test. As the results showed the
violation of normality for all variables (P < 0.001), the latent structure of the 24-item BPRS
was examined following Costello and Osborne's (2005) recommendations. Thus, we carried
out an Exploratory Factor Analysis (EFA) and extracted factors using the principal axis
factors method. The number of factors retained for rotation was determined with Horn's
parallel analysis using the Monte Carlo method for parallel analysis software (Watkins,
2000). Oblique rotation (the direct oblimin method) was preferred as factor independence
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was not assumed. To enable a clear interpretation of the factor analysis, only loadings of
0.30 or higher were considered (Tabachnick and Fidell, 2007). Items were forced in repeated
EFA analysis to obtain the most parsimonious and interpretable factor solution. The latter
had to fulfil the following criteria: (1) produce items with a factor loading of 0.30 or higher,
(2) produce factors comprising at least three items and (3) have as few cross-loading items
as possible.
Factorial scores were obtained by adding the items loading on a specific factor and dividing
this sum by the number of items belonging to the factor. This simple and most frequently
used method produces stable factor scores across samples and keeps the same metric scale
as the items (DiStefano et al., 2009). Sensitivity to change was verified through the
comparison of (a) pre–post BPRS scores, (b) the factors previously obtained in a sample of
patients with schizophrenia and mania (Ventura et al., 2000) and (c) the outcome groups
derived from SCL-90 R GSI. As pre–post BPRS comparisons did not provide complete
information about its sensitivity (e.g. are patients' after treatment scores normative?) and
because significant changes may also be due to its possible unreliability, there was a need to
include an independent measure of clinical change. Therefore, we have used the SCL-90 R
GSI to that end. Then, in order to identify patients' outcomes we have applied the Reliable
Change Index (RCI) and Clinical Significance (CS) criteria of Jacobson and Truax (1991).
Non-parametric statistics were used to compare group factorial scores. Thus, gender,
diagnosis and outcome groups' differences were examined with the Mann– Whitney U-test
or the Kruskal–Wallis one way analysis of variance for independent samples. Distributions
were examined with Pearson's Chi-Squared (χ2) test. Associations between variables were
analyzed with Spearman correlation coefficient. Sensitivity to change over time was
analyzed with the Wilcoxon signed-rank test for dependent samples. The Effect sizes (ES)
were computed with the ClinTools Software, Version 4.1 (Devilly, 2007) and their
magnitude of ES was interpreted as small (r = 0.10–0.29), medium (r = 0.30–0.49) or large
(r≥0.50) according to Cohen (1988). The analyses were computed with PASW 18 Statistics
(SPSS Inc., Chicago, IL, USA). The RCI and CS were computed with the ClinTools
Software, Version 4.1 (Devilly, 2007) considering the non-patient normal group SCL-90 R
GSI mean (S.D.) of 0.31 (0.31) (Derogatis, 1977). The criteria chosen were the RCI z-
score≤or ≥1.96 and the CS cut-off between the non-patient normal group and our samples'
mean with at least 95% confidence.
3. Results
3.1. Item descriptive statistics
Table 1 presents descriptive statistics for the BPRS items. The mean of fifteen (62.5%)
items is the score two. The range of 17 (70.8%) items is comprised between absent (score 1)
to severe/ extremely severe (score≥6). For 2 items (“distractibility”, “mannerisms and
posturing”) the range is weak. The presence of a symptom was defined as a score superior to
the score 1. According to this definition, “anxiety” or “depression” were present in almost
all patients (> 95%) while 4 items (“grandiosity”, “conceptual disorganization”,
“distractibility”, “mannerisms and posturing”) were seldom present (≤10%). The distribution
of the items was examined according to Bulmer's (1979) criteria. Thus, “anxiety” and
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“depression” items were negatively highly skewed (< −1) while the distribution of nearly
two-thirds of items (n = 14, 58.3%) was highly positively skewed (> + 1), indicating
respectively high and low ratings. Seven items (29.2%) are moderately skewed (between −1
and −0.05 or 0.05 and 1). Only, the distribution of the item “suicidality” is approximately
symmetric (skewness between −0.05 and 0.05).
3.2. Data screening
At intake, the sample size was higher than the minimal recommended sample size for EFA
analysis (n > 150) (Tabachnick and Fidell, 2007). The ratio of 10 patients per variable
corresponded to the suggested ratio of 10 to 1 (Nunnaly, 1978). The Kaiser–Meyer–Oklin
value of 0.69 exceeded the advised value of 0.60 (Tabachnick and Fidell, 2007). The
inspection of the correlation matrix revealed many coefficients greater than 0.3. Bartlett's
test of Sphericity was significant (χ2 (276) = 1048.42, P < 0.001). All these indicators
suggested that the data could be considered suitable for EFA. All items were included in the
EFA.
3.3. Exploratory Factorial Analysis (EFA)
The EFA without rotation revealed eight factors with eigenvalues superior to 1.0, explaining
58% of the variance. Two factors were dropped because they failed to exceed the criterion
value obtained by the Parallel Analysis after 100 runs. Thus, EFA was rerun forcing the
items into four-, five- and six-factor solutions. The four- and five-factor solutions were not
retained because they each had four items loading on several factors and because one factor
had only two items. The six factor solution was the most acceptable which explained 49% of
the variance. After rotation, the six-factor solution fulfilled the above mentioned criteria to
interpret the factors (see point 2.5). Twenty-two items out of the 24-item BPRS loaded on it.
The items “elevated mood” and “grandiosity” did not belong to any factor. Table 2 reports
the six retained factors and the item loadings grouped by size.
Factor I was saturated by “unusual thought content” and “suspiciousness” and to a lesser
degree by “hallucination”. It was interpreted as “Reality distortion”. Factor II was mainly
loaded by two items “motor activity” and “excitation”; “distractibility” and “tension” loaded
to a lower extent. It was defined as “Activation”. Factor III consisted of “blunted affect”,
“emotional withdrawal”, “motor retardation” and “uncooperativeness” and it is interpretable
as “Apathy”. Factor IV comprised items relating to “Mood disturbance”, that is
“depression”, “anxiety”, “suicidality” and “guilt” items. This factor also includes the
“suspiciousness” item, which is a psychotic feature, but at a much lower loading than for
“Reality distortion”. Factor V is principally composed of “conceptual disorganization” while
“disorientation” and “bizarre behaviour” had low communalities. Hence, we interpreted this
factor as “Disorganization”. Factor VI grouped “somatic concern”, “hostility” and
“mannerisms and posturing”. It is interpreted as “Somatization”. These factors explained
correspondingly, 13.04%, 10.98%, 7.06%, 6.73%, 5.63% and 5.40% of the variance. It is to
be noted that the item “suspiciousness” showed cross-loadings on the “Reality distortion”
and “Mood disturbance” factors. As the “tension” item loaded very similarly with the
“Mood disturbance” and “Activation” factors it was excluded from the analysis. As shown
in Table 3, the six dimensions are weakly correlated.
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The “Mood disturbance ” factor scores were normally distributed (Kolmogorov–Smirnov
test P > 0.05) indicating that most patients present mild to moderate depressive symptoms,
whereas the distribution of the other factor scores was not normal (Kolmogorov–Smirnov
test P < 0.001) and was strongly skewed indicating that a small proportion of patients
presented high severity on these dimensions.
3.4. Group differences and factor associations
Table 4 presents the results of group comparison and factor association. Age was not
correlated to the 24-item BPRS factor scores. However, we found some gender differences.
Women displayed significantly less “Apathy” and more “Somatization” features than men.
Nevertheless, these differences did not survive the Bonferroni correction for multiple
comparisons.
There were no significant differences between the depressive mood disorder (F32) and the
recurrent depressive disorder (F33) patient groups, between medication groups (drug free
versus monotherapy versus polytherapy) and between employed and non-employed patient
groups with regard to the 24-item BPRS scores.
3.5. Sensitivity to change
All participants were asked to complete the 24-item BPRS and the SCL-90 R after 8 weeks
(± 1 week). A group of 99 patients agreed, 59 of whom were women (59.99%), with a mean
age of 41.90 (S.D. = 11.61; range, 19–63) years. Eighty four patients completed both
instruments. At intake, no difference in the 24-item BPRS variables and socio-demographic
characteristics was found between this group and the group that did not participate in the
follow-up (all P > 0.10).
3.5.1. Pre–post factors comparisons—To assess the change in symptoms over time,
both the total 24-item BPRS score and the average composite scores of each factor were
considered. As shown in Table 5, the sensitivity of the BPRS dimensions obtained herein is
very similar to the one using the dimensions obtained by Ventura et al. (2000). This appears
especially clear for the “Mood Disturbance”, “Activation” and “Apathy” dimensions
compared to “Depression–Anxiety”, “Manic-hostility” and “Negative Symptoms”. In
addition to Ventura et al. (2000), we also found “Disorganization”, “Reality distortion” and
“Somatization” dimensions, these two latter being sensitive to change. According to Cohen's
(1988) rule of thumb, the effect sizes were small for “Reality distortion”, “Apathy” and
“Disorganization”, moderate for the 24-item BPRS total and “Somatization” and large for
“Mood disturbance”. No change was observed on the “Activation” factor score.
3.5.2. Groups' outcomes comparisons—The RCI and CS computed for the SCL-90 R
GSI score changes allow us to classify patients after intervention according to Wise (2004)
as Recovered (n = 31) if both RCI and CS were met (reliable change criteria and scores shift
on the normative range), Improved (n = 21) if only RCI criteria was met (reliable change
criteria and scores remain in the pathological range), Unchanged (n = 10) if none of the two
criteria was met (scores remain in the pathological range) or Deteriorated (n = 7) if RCI
criteria was met in the negative direction (scores worsen). In addition, we considered also a
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No distress group (n = 15) (SCL-90 R GSI scores are normative at admission and
discharge). The scores of each dimension and total of the 24-items BPRS of these five
outcome groups were compared both at admission and at discharge. Table 6 shows the mean
(S.D.) and the results of the comparisons. P values were adjusted for each time (P = 0.05/7
variables = 0.007) and for the number of group comparisons (P = 0.05/10 comparisons =
0.005). Only the results reaching statistical significance after adjustment for multiple
comparisons are considered. At admission, only “Reality distortion” was statistically
significant. Post hoc analyses indicate that the No Distress group has lower “Reality
distortion” scores than the Recovered (Mann–Whitney U-test, z = −3.24, P = 0.001),
Improved (Mann–Whitney U-test, z = −3.71, P < 0.001) and Unchanged (Mann–Whitney U-
test, z = −2.94, P = 0.005) groups. No other differences were found. At discharge, “Reality
distortion”, “Mood disturbance” and BPRS total score were significant. Post hoc analyses
show significant differences for the following comparisons. For “Reality distortion”, the No
distress Group scored lower than the Deteriorated (Mann–Whitney U-test, z = −3.01, P =
0.003) group. For “Mood disturbance” the No distress Group scored lower than Improved
(Mann–Whitney U-test, z = −3.55, P = 0.001), Unchanged (Mann–Whitney U-test, z =
−3.39, P < 0.001) and Deteriorated (Mann–Whitney U-test, z = −2.71, P = 0.005) groups
and the Recovered group scored lower than the Improved (Mann– Whitney U-test, z =
−4.65, P < 0.001), the Unchanged (Mann– Whitney U-test, z = −4.02, P < 0.001) and the
Deteriorated (Mann–Whitney U-test, z = −3.41, P < 0.001) groups. Finally, for BPRS total
score the Deteriorated group scored higher than the No distress (Mann–Whitney U-test, z =
−2.83, P = 0.003) group. The Recovered group scored lower than the Improved (Mann–
Whitney U-test, z = −4.38, P < 0.001), the Unchanged (Mann–Whitney U-test, z = −3.76, P
< 0.001) and the Deteriorated (Mann–Whitney U-test, z = −3.67, P < 0.001) groups. No
other differences reached statistical significance.
4. Discussion
The current study, to the best of our knowledge, is the first to investigate the symptom
dimensions and the sensitivity to change of the 24-item BPRS in a sample of outpatients
with unipolar depression. Therefore we could not directly compare our findings to those of
previous studies. In fact, previous research using the BPRS 24 was done in different clinical
settings and with psychotic patients or used the18-item BPRS or other instruments with
patients suffering from depression.
Regarding symptom dimensions, a six-factor solution was the most parsimonious,
interpretable and clinically relevant. As expected, we found a “Mood disturbance”
component including symptoms typically related to depression and anxiety. A “Depression”
factor was also found in unipolar depressive patients using the 18-item BPRS (Biancosino et
al., 2010). A very similar “Depression–Anxiety” dimension emerged also in factorial studies
of the 24-item BPRS in patients with schizophrenia (Burger et al., 1997; Dingemans et al.,
1995; Kopelowicz et al., 2008; Picardi et al., 2008; Thomas et al., 2004; Van der Does et al.,
1993; Ventura et al., 2000). However, this factor did not emerge in patients with Bipolar
Affective Disorders (Picardi et al., 2008). This latter result suggests that the 24-item BPRS
factor structure may vary according to patient sample studied.
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The “Reality distortion” dimension, characterized by items assessing psychosis, is very
similar to the “Psychoticism” factor reported by Biancosino et al. (2010). At first glance, this
could appear somewhat surprising as in our sample only two patients had a diagnosis of
depressive disorder with psychotic features. However, psychotic-like symptoms are very
common in patients with depression (Perlis et al., 2011). Our findings also confirm reports
using other assessment instruments isolating a “Psychosis” component in patients with
unipolar depression (Cassano et al., 2009; Harvey et al., 2009; Serretti et al., 1998). This is
also in line with cognitive theory of depression claiming that this disorder is characterized
by several irrational beliefs (Beck et al., 1979; McDermut et al., 1997; White et al., 1992),
and with the hypothesis that depression can lead to an exacerbation of positive psychotic
symptoms (Yung et al., 2007). Studies of patients with schizophrenia or with bipolar
affective disorder also identified this BPRS factor which was variously labelled “Positive
symptoms”, “Thinking Disorder” or “Thought Disturbance” (Burger et al., 1997; Dingemans
et al., 1995; Kopelowicz et al., 2008; Picardi et al., 2008; Thomas et al., 2004; Van der Does
et al., 1993; Ventura et al., 2000). However, it should be reminded that the presence of
psychotic features in depression does not mean that all patients have psychosis.
The “Activation” factor is comprised of the “motor hyperactivity”, “excitement” and
“distractibility” items also found in bipolar disorder and schizophrenia (e.g., Kopelowicz et
al., 2008; Picardi et al., 2008; Thomas et al., 2004; Ventura et al., 2000). This is a strength of
the 24-item BPRS compared to the 18-item BPRS which failed to produce an activation
dimension in unipolar depression (Biancosino et al., 2010). Our findings also add support
for clinical relevance of the “Activation” dimension observed in unipolar depressed patients
(Akiskal and Benazzi, 2006; Biondi et al., 2005).
The “Apathy” dimension found here measures the emotional impoverishment aspect of the
Apathy model (Starkstein et al., 2001). Our findings represent additional support for the
distinction between depression and apathy (Biancosino et al., 2010; Klaassen et al., 2011;
Starkstein et al., 2001). However, the “Apathy” dimension was not correlated with age in
unipolar depressed patients as reported in other studies (e.g., Biancosino et al., 2010). It is
also worthwhile to mention that the “Apathy” dimension overlapped part of the labelled
“Negative symptoms” dimension observed in patients with schizophrenia (e.g., Burger et al.,
1997; Dingemans et al., 1995; Kopelowicz et al., 2008; Thomas et al., 2004; Van der Does
et al., 1993; Ventura et al., 2000). This suggests that BPRS dimensions comprising similar
symptoms may be differently labelled and should be interpreted according to the diagnosis.
The “Disorganization” factor consists of cognitive (“conceptual disorganization” and
“disorientation” items) and behavioural (“bizarre behaviour”) features. Factor analyses of
the 18 and 24-item BPRS have also reported a “Disorganization” factor in patients with
schizophrenia (Van der Does et al., 1993). Disorganization is the core item of this factor and
is often included in the psychotic dimension in patients with schizophrenia (e.g., Burger et
al., 1997; Dingemans et al., 1995; Kopelowicz et al., 2008; Thomas et al., 2004; Van der
Does et al., 1993; Ventura et al., 2000) while for patients with mood disorders (manic and
depressive) the “disorganization” item is related to “Apathy” items (Biancosino et al., 2010;
Picardi et al., 2008). In our patient sample, the “Disorganization” dimension may represent
the negative impact of actual emotional crisis on everyday life functioning.
Zanello et al. Page 9
Psychiatry Res. Author manuscript; available in PMC 2014 June 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
The sixth factor is more difficult to interpret because it includes the “somatic concern”,
“hostility”, and “mannerisms and posturing” items which are conceptually not related.
Looking at their definition and scoring in the BPRS manual, it is likely that the lower scores
could be considered as various manifestations of physical sensations. Thus, we named this
factor “Somatization”. All these items are part of the “Dysphoria” dimension found by
Biancosino et al. (2010). It is important to point out that the prevalence of somatic
symptoms and irritability is commonly reported in major depression (Kapfhammer, 2006;
Perlis et al., 2011; Trivedi, 2004; Tylee and Gandhi, 2005). Somatic symptoms and
irritability were observed in approximately two-thirds of our patients (see Table 1). The
presence of the “mannerisms and posturing” item in this factor, a feature more often
observed in patients with schizophrenia, may be explained by the fact that in some patients
with depression, irritability may mimic mannerism and posturing (Féline, 1991). In our
sample women reported higher “Somatization” scores than men. This finding replicates
those of several previous studies (Marcus et al., 2005; Silverstein, 1999; Silverstein and
Patel, 2011).
Although we used an oblique rotation, only weak correlations were found among factors.
The highest association was observed between “Reality distortion” and “Disorganization”.
This confirms previous findings suggesting that these two psychotic features may represent
two distinct but related dimensions (Ventura et al., 2013).
Overall, the factorial structure of the 24-item BPRS found here suggests that in unipolar
depression it is important to assess additional symptoms other than those traditionally
measured by specific scales developed to only evaluate depressive symptoms. Indeed, the
identification of various symptom dimensions is in accordance with the dimensional
approach to depression psychopathology as a complement to categorical depression
approach (Van Praag et al., 1990; Van Praag, 1995; Goldberg, 2000; Biondi et al., 2005).
Concerning the sensitivity to change of the “Mood Disturbance”, “Activation” and “Apathy”
dimensions, they are very similar to the one of the “Depression–Anxiety”, “Manic-hostility”
and “Negative Symptoms” dimensions reported in patients with schizophrenia and mania
(e.g. Ventura et al., 2000). This is not surprising as these dimensions regroup very similar
items. The “Disorganization” dimension is less sensitive to change than the “Reality
distortion” and “Somatization” dimensions. The “Activation” dimension failed to reach
statistical significance. This latter result may be explained by a floor effect and could be
partially attributed to sample composition. In fact, none of the patients had psychosis (e.g.,
schizophrenia) or an acute manic disorder which would likely have higher “Activation”
scores than unipolar depression.
These findings lead to some suggestions for the use of 24-item BPRS with patients
presenting unipolar depression. If the clinician considers only the general level of
psychiatric symptom severity, he will ignore important information, thus it also becomes
essential to take into account the profile of factor scores. Monitoring the symptoms regularly
with a single instrument such as the 24-item BPRS could also be central to adapting
pharmacological and therapeutic treatments (e.g., in a Crisis Centre); this could also be
useful to document hospitalizations or the situation at discharge.
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However, some limitations may impede the generalization of our findings. First, the 24-item
BPRS was not administered to all patients referred to the CIC but only to a selected sample
that agreed to participate in the study. Second, the validity of the clinical diagnosis may be
criticized because it was not ascertained with standardized instruments (e.g., SCID,
Structured Clinical Interview for DSM-IV, First et al., 1996). Third, the comorbidities (e.g.,
medical conditions, substance abuse) were not considered, which may have confounding
effects. Fourth, the factorability of data may also be questionable because several items were
unrelated to others and some symptom items failed to contribute to the factor structure.
Moreover, given the exploratory nature of the study, we chose a simple method to calculate
factor scores. Future research should consider using more sophisticated statistical procedures
(see DiStefano et al. (2009)). Fifth, the convergent validity of the 24-item BPRS remained
unknown because of the absence of other symptom measures. Sixth, patients with
psychiatric diagnoses other than unipolar depression were not included; thus the
discriminant validity of the 24-item BPRS could not be verified. Future research has to
consider these limitations. Studies should not only confirm the factor solution found herein
but also verify the convergent validity of the 24-item BPRS with other well-known and
more frequently used instruments for assessing unipolar depression. The effects of socio-
demographic variables, such as marital and socio-economic status, crisis type (e.g., family
relations, work-related problems) and psychiatric background of patients (e.g., previous
hospitalization) should also be examined in larger samples. Finally, the fact that Crisis
Centres are not part of all health care systems prevents the generalization of our findings to
inpatients with unipolar depression. Thus, future research should verify the stability of the
factor structure of the 24-item BPRS in patients admitted to acute hospital wards. Further
differences between patient groups should be considered (e.g. inpatients admitted for a long
stay versus for a short stay versus outpatients admitted in a Crisis Centre versus outpatients
of ambulatory psychiatric units).
In summary, the current study should be considered as a first step towards the examination
of the 24-BPRS psychometric properties in patients with unipolar depression. Despite its
limitations, the findings showed that the 24-item BPRS could be a promising, valid, broad
clinical instrument to routinely monitor psychopathology in outpatients with unipolar
depression and to evaluate the effect of treatments.
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